Literature DB >> 9236860

Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia.

Z J Song1, H K Johansen, V Faber, N Høiby.   

Abstract

In an athymic rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis (CF), we studied the effects of the Chinese herb ginseng. Rats were treated subcutaneously with ginseng extracts (25 mg/kg) once a day for 10 days after challenge with P. aeruginosa embedded in alginate beads. We found that ginseng treatment significantly reduced bacterial load (p < 0.02) and the number of mast cells in the lungs (p < 0.01). Furthermore, it decreased the severity of lung pathology (p < 0.02) and lowered serum anti-P. aeruginosa IgM and IgA antibody levels (p < 0.004, p < 0.04) compared to the control group. The down-regulated specific humoral immunity in the ginseng-treated group and the fact that athymic rats have a severely compromised T-cell-mediated immune reactivity due to the absence of thymus might suggest an activation of innate immunity after ginseng treatment. Our findings indicate that ginseng treatment increases the resistance of the athymic rats to P. aeruginosa lung infection. We therefore think that ginseng has promising potential as a natural medicine for stimulation of the immune system in CF patients with chronic P. aeruginosa lung infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236860

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  11 in total

Review 1.  Plant products as antimicrobial agents.

Authors:  M M Cowan
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells.

Authors:  R Friedl; T Moeslinger; B Kopp; P G Spieckermann
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

3.  Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.

Authors:  Zhijun Song; Hong Wu; Per Mygind; Dora Raventos; Carsten Sonksen; Hans-Henrik Kristensen; Niels Høiby
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Panax ginseng has anti-infective activity against opportunistic pathogen Pseudomonas aeruginosa by inhibiting quorum sensing, a bacterial communication process critical for establishing infection.

Authors:  Z Song; K F Kong; H Wu; N Maricic; B Ramalingam; H Priestap; L Schneper; J M E Quirke; N Høiby; K Mathee
Journal:  Phytomedicine       Date:  2010-11       Impact factor: 5.340

5.  Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.

Authors:  R M Helliwell; C O ShioukHuey; K Dhuna; J C Molero; J-M Ye; C C Xue; L Stokes
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

6.  Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia.

Authors:  Z Song; A Kharazmi; H Wu; V Faber; C Moser; H K Krogh; J Rygaard; N Hoiby
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

7.  Selective early production of CCL20, or macrophage inflammatory protein 3alpha, by human mast cells in response to Pseudomonas aeruginosa.

Authors:  Tong-Jun Lin; Lauren H Maher; Kaede Gomi; Jeffrey D McCurdy; Rafael Garduno; Jean S Marshall
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

8.  Aging increases the expression of lung CINCs and MCP-1 in senile patients with pneumonia.

Authors:  Wei Li; Cheng Ding; Shaojun Yin
Journal:  Oncotarget       Date:  2017-09-27

9.  Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System.

Authors:  Soowon Kang; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

10.  Aging reduces the expression of lung CINC and MCP-1 mRNA in a P. aeruginosa rat model of infection.

Authors:  Jie Wen; Cheng-Mei Li; Li Gu; Shao-jun Yin; Wei Li; Rong Yang
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.